Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
about
The dual regulatory role of miR-204 in cancerA dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cellsE74-like factor inhibition induces reacquisition of hormone sensitiveness decreasing period circadian protein homolog 1 expression in prostate cancer cells.The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy.Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.The transcription factor SPDEF suppresses prostate tumor metastasisA Comprehensive NGS Data Analysis of Differentially Regulated miRNAs, piRNAs, lncRNAs and sn/snoRNAs in Triple Negative Breast Cancer.The transcription factor sterile alpha motif (SAM) pointed domain-containing ETS transcription factor (SPDEF) is required for E-cadherin expression in prostate cancer cells.Genome-wide identification of target genes for miR-204 and miR-211 identifies their proliferation stimulatory role in breast cancer cellsGADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migrationSPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.Role of microRNAs in lung development and pulmonary diseasesmiR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma.PDEF in prostate cancer.Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer.Signatures of prostate-derived Ets factor (PDEF) in cancer.miR-204 is dysregulated in metastatic prostate cancer in vitro.microRNA-204 modulates chemosensitivity and apoptosis of prostate cancer cells by targeting zinc-finger E-box-binding homeobox 1 (ZEB1).Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma.A tight junction between E-Cadherin and the prostate tumor suppressor SPDEFRAS/ERK pathway transcriptional regulation through ETS/AP-1 binding sites.Nephroblastomas show low expression of microR-204 and high expression of its target, the oncogenic transcription factor MEIS1.miR-204 Shifts the Epithelial to Mesenchymal Transition in Concert with the Transcription Factors RUNX2, ETS1, and cMYB in Prostate Cancer Cell Line Model
P2860
Q28078421-5DA5E8A6-6795-4BE5-B2DF-D33C083C7024Q28573536-662D9167-5FAE-438A-9974-10C197F4A485Q30371371-7BD867E4-0C88-4715-AAE0-6C20117CD1DDQ33688960-A5E225D5-A35C-4297-B6A4-99314ACF0452Q34257025-D6D10E07-2671-40A4-B0B3-41EA30AE0E03Q34687078-8F3C2C35-4A3C-4E68-AE35-19A7C7449EBFQ35493982-AFBCBEBA-51A8-4B4C-A0FE-ABCD9041898DQ35539939-E2DBBAF2-29FE-4684-BA9E-6381E5984CCBQ35758944-BA08144B-C927-4BB5-A8F6-03BD8C844F8AQ36215965-E0CCC0FD-06DE-4BD4-881F-93EADD736A64Q36331326-65EB3ED3-61B0-45E2-BCBD-C5292F912CBFQ36796922-63ACB801-51E5-481D-8B81-EE0CD3F99EE5Q36845833-CCF19217-D83E-4E82-9F87-0E5ACFB69252Q37046475-33E1DB1E-E3DF-4749-B15C-0BFA3B07352FQ37081755-457DFC89-2468-45D6-8C5D-4E6CB76BB07FQ37133793-D8A08944-592A-49EC-A683-D0344359952BQ37577131-6C02427B-9883-40BB-B609-2877736CB9CCQ37907174-80A921C9-A9E6-4B09-A38E-182BB14126ECQ38723072-242435C8-47D7-4F76-B9D3-C31DE5E81AF4Q38747388-C2A0CC00-B90C-49D3-8038-F2F3D39213A7Q38915627-2286E778-E236-4EE6-9F9C-B96609110405Q41549268-C3B51F4C-ED1F-4008-8BB5-5447FE25F100Q41592766-5DB52FD8-1173-4C01-BF0F-A6EC68D93A36Q41863094-7AF081F9-CB6C-4B6F-BDCE-51696F64CD8AQ41879970-0DB8E89E-6BB5-4EC5-AB5E-EACD805C08F9Q42232350-7DF975DA-956E-4ECF-AACF-0FA616E92F25Q59051976-4B629B3A-C4DA-44E7-BE64-F62CACA7C0CF
P2860
Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mechanisms and functional cons ...... g prostate cancer progression.
@ast
Mechanisms and functional cons ...... g prostate cancer progression.
@en
type
label
Mechanisms and functional cons ...... g prostate cancer progression.
@ast
Mechanisms and functional cons ...... g prostate cancer progression.
@en
prefLabel
Mechanisms and functional cons ...... g prostate cancer progression.
@ast
Mechanisms and functional cons ...... g prostate cancer progression.
@en
P2093
P2860
P356
P1433
P1476
Mechanisms and functional cons ...... ng prostate cancer progression
@en
P2093
Amanda C LaRue
David P Turner
Dennis K Watson
Mohamed M Desouki
Omar Moussa
Patricia M Watson
Victor I Semenchenko
P2860
P304
P356
10.1002/PROS.21389
P577
2011-03-28T00:00:00Z